[Recent aspects of Neuro-Behcet's disease]
1Department of Rheumatology and Infectious Diseases, Kitasato University School of Medicine.
Brain and Nerve = Shinkei Kenkyu No Shinpo
|November 9, 2013
Summary
Neuro-Behcet's disease (NBD) has acute and chronic forms. Acute NBD responds to steroids and colchicine, while chronic NBD requires methotrexate or infliximab for treatment.
Area of Science:
- Neurology
- Immunology
- Rheumatology
Context:
- Behcet's disease frequently involves the central nervous system, manifesting as neuro-Behcet's disease (NBD).
- NBD presents in two primary forms: acute meningoencephalitis and chronic progressive neurological decline.
- Magnetic resonance imaging (MRI) plays a crucial role in diagnosing NBD, revealing focal lesions in acute cases and brainstem atrophy in chronic cases.
Purpose:
- To delineate the distinct characteristics, diagnostic criteria, and therapeutic strategies for acute and chronic progressive neuro-Behcet's disease.
- To provide an overview of the current understanding of NBD pathophysiology and clinical management.
Summary:
- Acute NBD involves meningoencephalitis with MRI-detectable lesions and responds well to corticosteroids and colchicine for relapse prevention.
- Chronic progressive NBD is characterized by progressive dementia, ataxia, dysarthria, elevated CSF IL-6, and brainstem atrophy, often linked to male gender, HLA-B51, and smoking.
- Diagnostic criteria for acute NBD rely on CSF cell counts, while chronic progressive NBD diagnosis utilizes CSF IL-6 activity and MRI findings.
- Treatment for chronic progressive NBD is challenging, with low-dose methotrexate and infliximab showing efficacy in cases resistant to conventional therapies.
Impact:
- Establishes clear diagnostic guidelines for differentiating acute and chronic NBD based on specific biomarkers and imaging findings.
- Highlights effective treatment modalities for both forms of NBD, improving patient outcomes and guiding clinical practice.
- Provides a foundation for future research into the pathogenesis and targeted therapies for neuro-Behcet's disease.
More Related Videos
04:00Author Spotlight: Establishing a Practical and Cost-Effective Protocol for Corneal Sensitivity Testing in Clinical Settings
Published on: August 2, 2024
3.7K
08:05Bioluminescence and Near-infrared Imaging of Optic Neuritis and Brain Inflammation in the EAE Model of Multiple Sclerosis in Mice
Published on: March 1, 2017
8.8K
Related Concept Videos
01:26Encephalitis ll: Pathophysiology
30
Encephalitis is inflammation of the brain parenchyma caused by direct viral invasion or immune-mediated mechanisms triggered by infections or tumors. Both processes lead to neuronal injury, disrupted neurotransmission, and diverse neurological symptoms, often with overlapping clinical and pathological features.Autoimmune EncephalitisIn autoimmune encephalitis, antibodies target neuronal antigens on cell surfaces, synapses, or within neurons. A key example is anti-NMDAR encephalitis, which can...
30
01:19Encephalitis l: Introduction
27
Encephalitis is inflammation of the brain parenchyma, most often due to infections or autoimmune processes. It presents with neuropsychiatric features such as fever, altered mental status, behavioral changes, cognitive dysfunction, seizures, focal deficits, and sometimes autonomic instability. In some cases, the meninges are also involved, resulting in meningoencephalitis.Infectious CausesInfectious encephalitis is most commonly viral but can also result from bacterial, fungal, or parasitic...
27
01:26Nephrotic Syndrome II : Assessment and Medical Management
422
IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document...
422
01:19Multiple Sclerosis l: Introduction
31
Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...
31
01:24Nephrotic Syndrome I : Introduction
1.2K
Nephrotic Syndrome is a chronic kidney disorder defined by clinical findings such as severe proteinuria, hypoalbuminemia, hyperlipidemia, and edema. These symptoms result from damage to the glomeruli, the kidney’s filtering units, increasing their permeability to proteins.Definition and Meaning:Proteinuria, defined as the loss of more than 3.5 grams of protein per day in adults, is a crucial feature of nephrotic syndrome. This condition is often accompanied by edema, the accumulation of...
1.2K